Literature DB >> 28828712

Temporal trends in prevalence, incidence, and mortality for rheumatoid arthritis in Quebec, Canada: a population-based study.

Sonia Jean1,2, Marie Hudson3,4, Philippe Gamache1, Louis Bessette2,5, Paul R Fortin2,5, Gilles Boire6, Sasha Bernatsky7,8.   

Abstract

Health administrative data are a potentially efficient resource to conduct population-based research and surveillance, including trends in incidence and mortality over time. Our objective was to explore time trends in incidence and mortality for rheumatoid arthritis (RA), as well as estimating period prevalence. Our RA case definition was based on one or more hospitalizations with a RA diagnosis code, or three or more RA physician-billing codes, over 2 years, with at least one RA billing code by a rheumatologist, orthopedic surgeon, or internist. To identify incident cases, a "run-in" period of 5 years (1996-2000) was used to exclude prevalent cases. Crude age and sex-specific incidence rates were calculated (using data from 2001 to 2015), and sex-specific incidence rates were also standardized to the 2001 age structure of the Quebec population. We linked the RA cohort (both prevalent and incident patients) to the vital statistics registry, and standardized mortality rate ratios were generated. Negative binomial regression was used to test for linear change in standardized incidence rates and mortality ratios. The linear trends in standardized incidence rates did not show significant change over the study period. Mortality in RA was significantly higher than the general population and this remained true throughout the study period. Our prevalence estimate suggested 0.8% of the Quebec population may be affected by RA. RA incidence appeared relatively stable, and mortality was substantially higher in RA versus the general population and remained so over the study period. This suggests the need to optimize long-term RA outcomes.

Entities:  

Keywords:  Administrative data; Epidemiology; Mortality; Rheumatoid arthritis

Mesh:

Year:  2017        PMID: 28828712     DOI: 10.1007/s10067-017-3796-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

1.  The epidemiology of rheumatoid arthritis in Ontario, Canada.

Authors:  Jessica Widdifield; J Michael Paterson; Sasha Bernatsky; Karen Tu; George Tomlinson; Bindee Kuriya; J Carter Thorne; Claire Bombardier
Journal:  Arthritis Rheumatol       Date:  2014-04       Impact factor: 10.995

2.  Accuracy of Canadian health administrative databases in identifying patients with rheumatoid arthritis: a validation study using the medical records of rheumatologists.

Authors:  Jessica Widdifield; Sasha Bernatsky; J Michael Paterson; Karen Tu; Ryan Ng; J Carter Thorne; Janet E Pope; Claire Bombardier
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-10       Impact factor: 4.794

3.  Quebec Integrated Chronic Disease Surveillance System (QICDSS), an innovative approach.

Authors:  C Blais; S Jean; C Sirois; L Rochette; C Plante; I Larocque; M Doucet; G Ruel; M Simard; P Gamache; D Hamel; D St-Laurent; V Emond
Journal:  Chronic Dis Inj Can       Date:  2014-11

Review 4.  The consequences of rheumatoid arthritis: quality of life measures in the individual patient.

Authors:  L Pollard; E H Choy; D L Scott
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

5.  Surveillance of systemic autoimmune rheumatic diseases using administrative data.

Authors:  S Bernatsky; L Lix; J G Hanly; M Hudson; E Badley; C Peschken; C A Pineau; A E Clarke; P R Fortin; M Smith; P Bélisle; C Lagace; L Bergeron; L Joseph
Journal:  Rheumatol Int       Date:  2010-07-28       Impact factor: 2.631

6.  Observation period effects on estimation of systemic lupus erythematosus incidence and prevalence in Quebec.

Authors:  Ryan Ng; Sasha Bernatsky; Elham Rahme
Journal:  J Rheumatol       Date:  2013-06-15       Impact factor: 4.666

Review 7.  Joint inflammation and cytokine inhibition in rheumatoid arthritis.

Authors:  C Christodoulou; E H Choy
Journal:  Clin Exp Med       Date:  2006-03       Impact factor: 3.984

8.  Impact of rheumatoid arthritis on quality of life.

Authors:  Nigil Haroon; Amita Aggarwal; Able Lawrence; Vikas Agarwal; Ramnath Misra
Journal:  Mod Rheumatol       Date:  2007-08-20       Impact factor: 3.023

9.  Consensus statements for the use of administrative health data in rheumatic disease research and surveillance.

Authors:  Sasha Bernatsky; Lisa Lix; Siobhan O'Donnell; Diane Lacaille
Journal:  J Rheumatol       Date:  2012-11-01       Impact factor: 4.666

10.  An administrative data validation study of the accuracy of algorithms for identifying rheumatoid arthritis: the influence of the reference standard on algorithm performance.

Authors:  Jessica Widdifield; Claire Bombardier; Sasha Bernatsky; J Michael Paterson; Diane Green; Jacqueline Young; Noah Ivers; Debra A Butt; R Liisa Jaakkimainen; J Carter Thorne; Karen Tu
Journal:  BMC Musculoskelet Disord       Date:  2014-06-23       Impact factor: 2.362

View more
  8 in total

1.  The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review.

Authors:  Khalid Almutairi; Johannes Nossent; David Preen; Helen Keen; Charles Inderjeeth
Journal:  Rheumatol Int       Date:  2020-11-11       Impact factor: 2.631

Review 2.  Cardiovascular effects of approved drugs for rheumatoid arthritis.

Authors:  Fabiola Atzeni; Javier Rodríguez-Carrio; Călin D Popa; Michael T Nurmohamed; Gabriella Szűcs; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2021-04-08       Impact factor: 20.543

3.  Study of Factors Influencing Dry Eye in Rheumatoid Arthritis.

Authors:  Weifang Ma; Guoliang Wang; Xiaofeng Li; Huping Wu; Zuguo Liu; Nuo Dong; Cheng Li
Journal:  J Ophthalmol       Date:  2020-08-08       Impact factor: 1.909

4.  Comparative safety of biologic versus conventional synthetic DMARDs in rheumatoid arthritis with COPD: a real-world population study.

Authors:  Marie Hudson; Sophie Dell'Aniello; Sophie Shen; Teresa A Simon; Pierre Ernst; Samy Suissa
Journal:  Rheumatology (Oxford)       Date:  2020-04-01       Impact factor: 7.580

5.  Prevalence and Incidence of Rheumatoid Arthritis in Canadian First Nations and Non-First Nations People: A Population-Based Study.

Authors:  Carol A Hitchon; Sazzadul Khan; Brenda Elias; Lisa M Lix; Christine A Peschken
Journal:  J Clin Rheumatol       Date:  2020-08       Impact factor: 3.902

6.  The prevalence of rheumatoid arthritis in Spain.

Authors:  Lucía Silva-Fernández; Cristina Macía-Villa; Daniel Seoane-Mato; Raúl Cortés-Verdú; Antonio Romero-Pérez; Víctor Quevedo-Vila; Dolores Fábregas-Canales; Fred Antón-Pagés; Gustavo Añez; Anahy Brandy; Cristina Martínez-Dubois; Paula Rubio-Muñoz; Carlos Sánchez-Piedra; Federico Díaz-González; Sagrario Bustabad-Reyes
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

7.  Trends of multimorbidity in 15 European countries: a population-based study in community-dwelling adults aged 50 and over.

Authors:  Dyego L B Souza; Albert Oliveras-Fabregas; Eduard Minobes-Molina; Marianna de Camargo Cancela; Paola Galbany-Estragués; Javier Jerez-Roig
Journal:  BMC Public Health       Date:  2021-01-07       Impact factor: 3.295

8.  Physical and Emotional Burden of Rheumatoid Arthritis: Data from RA Matters, a Web-Based Survey of Patients and Healthcare Professionals.

Authors:  Rieke Alten; Mart van de Laar; Francesco De Leonardis; Nicole Tietz; Mariana Guerreiro; Ronald van Vollenhoven
Journal:  Rheumatol Ther       Date:  2019-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.